Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease
- PMID: 15867588
- DOI: 10.1097/01.mib.0000159663.62651.4f
Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease
Abstract
Background: Colorectal bacteria may play a role in the pathogenesis of inflammatory bowel disease (IBD). To test the hypothesis that, in affected patients, the numbers of potentially protective mucosal bacteria might be reduced and pathogenic species increased, we compared rectal mucosa-associated flora in patients with IBD and normal controls.
Methods: Snap-frozen rectal biopsies taken at routine diagnostic colonoscopy from 33 patients with ulcerative colitis, 6 patients with Crohn's disease, and 14 controls with normal colonoscopy were processed, and individual bacterial groups were counted using fluorescent in situ hybridization.
Results: Bacteria were mostly found apposed to the epithelial surface and within crypts. Epithelium-associated counts of bifidobacteria in active [median 15/mm of epithelial surface (range, 4-56), n = 14] and quiescent ulcerative colitis [26/mm (range, 11-140), n = 19] were lower than in controls [56/mm (range, 0-144), n = 14; P = 0.006 and P = 0.03, respectively]. Conversely, epithelium-associated Escherichia coli counts were higher in active [82/mm (range, 56-136)] than inactive ulcerative colitis [6/mm (range, 0-136), P = 0.0001] or controls [0/mm (range, 0-16), P < 0.0001]. Epithelium-associated clostridia counts were also higher in active [3/mm (range, 0-9)] than inactive colitis [0/mm (range, 0-9), P = 0.03] or controls [0/mm (range, 0-1); P = 0.0007]. Epithelium-associated E. coli counts were higher in Crohn's disease [42/mm (range, 3-90), n = 6] than controls (P = 0.0006). E. coli were also found as individual bacteria and in clusters in the lamina propria in ulcerative colitis and Crohn's disease but in none of the controls (P < 0.01). Numbers of Lactobacillus and Bacteroides showed no differences between patient groups.
Conclusions: The reduction in mucosa-associated bifidobacteria and increase in E. coli and clostridia in patients with IBD supports the hypothesis that an imbalance between potentially beneficial and pathogenic bacteria may contribute to its pathogenesis.
Comment in
-
Standards for bacterial identification by fluorescence In situ hybridization within eukaryotic tissue using ribosomal rRNA-based probes.Inflamm Bowel Dis. 2006 Aug;12(8):824-6; author reply 826-7. doi: 10.1097/00054725-200608000-00018. Inflamm Bowel Dis. 2006. PMID: 16917237 No abstract available.
Similar articles
-
Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis.J Clin Gastroenterol. 2019 Oct;53(9):660-672. doi: 10.1097/MCG.0000000000000961. J Clin Gastroenterol. 2019. PMID: 29210899
-
[Presence of intracellular Escherichia coli in patients with inflammatory bowel disease].Rev Med Chil. 2017 Sep;145(9):1129-1136. doi: 10.4067/s0034-98872017000901129. Rev Med Chil. 2017. PMID: 29424399 Spanish.
-
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.Gut. 2006 Dec;55(12):1760-7. doi: 10.1136/gut.2005.078824. Epub 2006 Apr 28. Gut. 2006. PMID: 16648155 Free PMC article.
-
Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.Dig Dis. 2014;32(4):475-83. doi: 10.1159/000358156. Epub 2014 Jun 23. Dig Dis. 2014. PMID: 24969297 Review.
-
Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India.J Gastroenterol. 2016 Jul;51(7):660-71. doi: 10.1007/s00535-016-1193-1. Epub 2016 Mar 19. J Gastroenterol. 2016. PMID: 26994772 Review.
Cited by
-
Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity.Dig Dis Sci. 2013 Oct;58(10):2756-66. doi: 10.1007/s10620-013-2744-4. Epub 2013 Jul 10. Dig Dis Sci. 2013. PMID: 23839339 Free PMC article. Review.
-
Complex host genetics influence the microbiome in inflammatory bowel disease.Genome Med. 2014 Dec 2;6(12):107. doi: 10.1186/s13073-014-0107-1. eCollection 2014. Genome Med. 2014. PMID: 25587358 Free PMC article.
-
The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview.Gastrointest Disord (Basel). 2019 Mar;1(1):75-105. doi: 10.3390/gidisord1010007. Epub 2018 Oct 18. Gastrointest Disord (Basel). 2019. PMID: 37577036 Free PMC article.
-
Bacterial colonization and intestinal mucosal barrier development.World J Clin Pediatr. 2013 Nov 8;2(4):46-53. doi: 10.5409/wjcp.v2.i4.46. eCollection 2013 Nov 8. World J Clin Pediatr. 2013. PMID: 25254174 Free PMC article. Review.
-
[Role of the gut microbiome in the pathogenesis and treatment of inflammatory bowel diseases].Inn Med (Heidelb). 2022 Oct;63(10):1022-1027. doi: 10.1007/s00108-022-01396-8. Epub 2022 Aug 31. Inn Med (Heidelb). 2022. PMID: 36044059 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical